Cargando…
Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980086/ https://www.ncbi.nlm.nih.gov/pubmed/35210590 http://dx.doi.org/10.1038/s41416-022-01765-y |
| _version_ | 1784681319520796672 |
|---|---|
| author | Slootbeek, Peter H. J. Kloots, Iris S. H. Smits, Minke van Oort, Inge M. Gerritsen, Winald R. Schalken, Jack A. Ligtenberg, Marjolijn J. L. Grünberg, Katrien Kroeze, Leonie I. Bloemendal, Haiko J. Mehra, Niven |
| author_facet | Slootbeek, Peter H. J. Kloots, Iris S. H. Smits, Minke van Oort, Inge M. Gerritsen, Winald R. Schalken, Jack A. Ligtenberg, Marjolijn J. L. Grünberg, Katrien Kroeze, Leonie I. Bloemendal, Haiko J. Mehra, Niven |
| author_sort | Slootbeek, Peter H. J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8980086 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89800862022-04-20 Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer Slootbeek, Peter H. J. Kloots, Iris S. H. Smits, Minke van Oort, Inge M. Gerritsen, Winald R. Schalken, Jack A. Ligtenberg, Marjolijn J. L. Grünberg, Katrien Kroeze, Leonie I. Bloemendal, Haiko J. Mehra, Niven Br J Cancer Correction Nature Publishing Group UK 2022-02-24 2022-04-01 /pmc/articles/PMC8980086/ /pubmed/35210590 http://dx.doi.org/10.1038/s41416-022-01765-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Slootbeek, Peter H. J. Kloots, Iris S. H. Smits, Minke van Oort, Inge M. Gerritsen, Winald R. Schalken, Jack A. Ligtenberg, Marjolijn J. L. Grünberg, Katrien Kroeze, Leonie I. Bloemendal, Haiko J. Mehra, Niven Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer |
| title | Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer |
| title_full | Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer |
| title_fullStr | Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer |
| title_full_unstemmed | Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer |
| title_short | Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer |
| title_sort | correction to: impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980086/ https://www.ncbi.nlm.nih.gov/pubmed/35210590 http://dx.doi.org/10.1038/s41416-022-01765-y |
| work_keys_str_mv | AT slootbeekpeterhj correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT klootsirissh correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT smitsminke correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT vanoortingem correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT gerritsenwinaldr correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT schalkenjacka correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT ligtenbergmarjolijnjl correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT grunbergkatrien correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT kroezeleoniei correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT bloemendalhaikoj correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer AT mehraniven correctiontoimpactofmoleculartumourboarddiscussionontargetedtherapyallocationinadvancedprostatecancer |